• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.23% Nasdaq Down 0.63%

    Omeros Corporation (OMER)

    -NasdaqGM
    23.14 Down 1.18(4.85%) Apr 27, 4:00PM EDT
    |After Hours : 23.14 0.00 (0.00%) Apr 27, 5:16PM EDT
    Add to Portfolio
    Prev Close:24.32
    Open:24.47
    Bid:22.08 x 100
    Ask:25.00 x 800
    1y Target Est:44.20
    Beta:1.64
    Earnings Date:May 11 - May 15 (Est.)
    Day's Range:22.93 - 24.85
    52wk Range:9.76 - 27.64
    Volume:352,216
    Avg Vol (3m):518,461
    Market Cap:874.74M
    P/E (ttm):N/A
    EPS (ttm):-2.22
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    OMERDown 4.85%874.74M
    ACADDown 6.03%3.62B
    ALKSDown 6.60%8.61B
    HRTXDown 11.07%N/A

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):1,705.65
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-2.06
    Quarterly EPS Est (Mar-15) :-0.63
    Mean Recommendation*:1.8
    PEG Ratio (5 yr expected):-0.14

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Omeros Corporation, a biopharmaceutical company, discovers, develops, and commercializes small-molecule and protein therapeutics, and orphan indications targeting inflammation, coagulopathies, and disorders of the central nervous system. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback